The effect of the pro-inflammatory cytokine tumor necrosis factor-alpha on human joint capsule myofibroblasts

Arthritis Research and Therapy

Volumn 12, Issue 1, 2010, Pages

  Mattyasovszky, Stefan G ^a   Hofmann, Alexander ^a   Brochhausen, Christoph ^a   Ritz, Ulrike ^a   Kuhn, Sebastian ^a   Wollstädter, Jochen ^a   Schulze Koops, Hendrik ^b   Müller, Lars P ^a   Watzer, Bernhard ^c   Rommens, Pol M ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Eicosanoid and Mass Spectrometry Laboratory   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; DICLOFENAC; INFLIXIMAB; PROSTAGLANDIN E2; PROSTAGLANDIN F1 ALPHA; PROSTAGLANDIN F2 ALPHA; TUMOR NECROSIS FACTOR ALPHA; ACTIN; ANTIRHEUMATIC AGENT; AUTACOID; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; MONOCLONAL ANTIBODY; PROSTAGLANDIN F; PROSTAGLANDIN F1;

ADULT; AGED; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; DOWN REGULATION; ELBOW; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; JOINT CAPSULE; MALE; MYOFIBROBLAST; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; CONTRACTURE; DRUG EFFECT; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; HIP; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTINS; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; CONTRACTURE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYTOKINES; DICLOFENAC; DINOPROST; DINOPROSTONE; ELBOW JOINT; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HIP JOINT; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; JOINT CAPSULE; MALE; MIDDLE AGED; PROSTAGLANDINS F; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955502024     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2902     Document Type: Article

References (35)

1. Cooney WP. Contractures of the elbow. The Elbow and Its Disorders 1993, 464-475. Philadelphia, PA: WB Saunders, Morrey BF.
2. Bunker TD. Frozen shoulder: unravelling the enigma. Ann R Coll Surg Engl 1997, 79:210-213. 2502880, 9196344.
3. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007, 127:526-537. 10.1038/sj.jid.5700613, 17299435.
4. Gabbiani G, Ryan GB, Majne G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971, 27:549-550. 10.1007/BF02147594, 5132594.
5. Serini G, Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res 1999, 250:273-283. 10.1006/excr.1999.4543, 10413583.
6. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002, 3:349-363. 10.1038/nrm809, 11988769.
7. Hildebrand KA, Zhang M, Hart DA. Myofibroblast upregulators are elevated in joint capsules in posttraumatic contractures. Clin Orthop Relat Res 2007, 456:85-91. 10.1097/BLO.0b013e3180312c01, 17195814.
8. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 2005, 13:7-12. 10.1111/j.1067-1927.2005.130102.x, 15659031.
9. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol 2007, 170:1807-1816. 10.2353/ajpath.2007.070112, 1899462, 17525249.
10. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003, 200:500-503. 10.1002/path.1427, 12845617.
11. Hinz B, Mastrangelo D, Iselin CE, Chaponnier C, Gabbiani G. Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol 2001, 159:1009-1020. 1850455, 11549593.
12. Berndt A, Kosmehl H, Katenkamp D, Tauchmann V. Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix. Pathobiology 1994, 62:55-58. 10.1159/000163879, 7524526.
13. Tomasek J, Rayan GM. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts. J Hand Surg Am 1995, 20:450-455. 10.1016/S0363-5023(05)80105-4, 7642925.
14. Ettema AM, Amadio PC, Zhao C, Wold LE, An KN. A histological and immunohistochemical study of the subsynovial connective tissue in idiopathic carpal tunnel syndrome. J Bone Joint Surg Am 2004, 86-A:1458-1466.
15. Bunker TD, Reilly J, Baird KS, Hamblen DL. Expression of growth factors, cytokines and matrix metalloproteinases in frozen shoulder. J Bone Joint Surg Br 2000, 82:768-773. 10.1302/0301-620X.82B5.9888, 10963182.
16. Mauviel A, Qiu CY, Dong W, Evans CH, Uitto J. Transcriptional interactions of transforming growth-factor-beta with pro-inflammatory cytokines. Curr Biol 1993, 3:822-831. 10.1016/0960-9822(93)90216-B, 15335815.
17. Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem 2000, 275:15220-15225. 10.1074/jbc.275.20.15220, 10809757.
18. Goldberg MT, Han YP, Yan C, Shaw MC, Garner WL. TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing. J Invest Dermatol 2007, 127:2645-2655. 10.1038/sj.jid.5700890, 2366884, 17554369.
19. Sullivan DE, Ferris M, Pociask D, Brody AR. Tumor necrosis factor-alpha induces transforming growth factor-beta1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. Am J Respir Cell Mol Biol 2005, 32:342-349. 10.1165/rcmb.2004-0288OC, 15653932.
20. Siwik DA, Chang DL, Colucci WS. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 2000, 86:1259-1265.
21. Grinnell F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 2003, 13:264-269. 10.1016/S0962-8924(03)00057-6, 12742170.
22. de Hemptinne I, Gallant-Behm CL, Noack CL, Parreno J, Hart DA. Dermal fibroblasts from red Duroc and Yorkshire pigs exhibit intrinsic differences in the contraction of collagen gels. Wound Repair Regen 2008, 16:132-142. 10.1111/j.1524-475X.2007.00340.x, 18211585.
23. Miki H, Mio T, Nagai S, Hoshino Y, Tsutsumi T, Mikuniya T, Izumi T. Glucocorticoid-induced contractility and F-actin content of human lung fibroblasts in three-dimensional culture. Am J Physiol Lung Cell Mol Physiol 2000, 278:L13-L18.
24. Schweer H, Watzer B, Seyberth HW. Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry. J Chromatogr 1994, 652:221-227. 10.1016/0378-4347(93)E0408-I, 8006107.
25. Agostini C, Gurrieri C. Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 2006, 3:357-363. 10.1513/pats.200601-010TK, 16738201.
26. Liu X, Kelm RJ, Strauch AR. Transforming growth factor beta1-mediated activation of the smooth muscle alpha-actin gene in human pulmonary myofibroblasts is inhibited by tumor necrosis factor-alpha via mitogen-activated protein kinase kinase 1-dependent induction of the Egr-1 transcriptional repressor. Mol Biol Cell 2009, 20:2174-2185. 10.1091/mbc.E08-10-0994, 2669025, 19261809.
27. Porter KE, Turner NA, O'Regan DJ, Ball SG. Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. Cardiovasc Res 2004, 64:507-515. 10.1016/j.cardiores.2004.07.020, 15537504.
28. Theiss AL, Simmons JG, Jobin C, Lund PK. Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. J Biol Chem 2005, 280:36099-36109. 10.1074/jbc.M505291200, 16141211.
29. Gallois C, Habib A, Tao J, Moulin S, Maclouf J, Mallat A, Lotersztajn S. Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2. J Biol Chem 1998, 273:23183-23190. 10.1074/jbc.273.36.23183, 9722548.
30. Mariani TJ, Arikan MC, Pierce RA. Fibroblast tropoelastin and alpha-smooth-muscle actin expression are repressed by particulate-activated macrophage-derived tumor necrosis factor-alpha in experimental silicosis. Am J Respir Cell Mol Biol 1999, 21:185-192.
31. Fang Q, Liu X, Al-Mugotir M, Kobayashi T, Abe S, Kohyama T, Rennard SI. Thrombin and TNF-alpha/IL-1beta synergistically induce fibroblast-mediated collagen gel degradation. Am J Respir Cell Mol Biol 2006, 35:714-721. 10.1165/rcmb.2005-0026OC, 2643297, 16858010.
32. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999, 341:738-46. 10.1056/NEJM199909023411006, 10471461.
33. Verrecchia F, Tacheau C, Wagner EF, Mauviel A. A central role for the JNK pathway in mediating the antagonistic activity of pro-inflammatory cytokines against transforming growth factor-beta-driven SMAD3/4-specific gene expression. J Biol Chem 2003, 278:1585-93. 10.1074/jbc.M206927200, 12426318.
34. Kolodsick JE, Peters-Golden M, Larios J, Toews GB, Thannickal VJ, Moore BB. Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am J Respir Cell Mol Biol 2003, 29:537-544. 10.1165/rcmb.2002-0243OC, 12738687.
35. Bort R, Ponsoda X, Jover R, Gomez-Lechon MJ, Castell JV. Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity. J Pharmacol Exp Ther 1999, 288:65-72.